Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec;39(12):e70347.
doi: 10.1111/ctr.70347.

The Role of Albuminuria in Diagnosing and Stratifying Kidney Disease in Heart Transplant Recipients: A KDIGO Criteria-Based Analysis

Pedro Caravaca-Pérez  1   2 , Anthony Salazar Rodriguez  1 , José Jesús Broseta  2   3   4   5 , Eduard Solé Gonzalez  1   2 , María Ángeles Castel  1   2   6 , Juan José Rodriguez  1   2 , Elena Cuadrado-Payán  2   3   4 , Diana Rodriguez-Espinosa  2   3   4 , Elena Sandoval  2   7 , Aleix Cases  2 , Ana García-Álvarez  1   2   5   8 , Marta Farrero  1   2   5
Affiliations

The Role of Albuminuria in Diagnosing and Stratifying Kidney Disease in Heart Transplant Recipients: A KDIGO Criteria-Based Analysis

Pedro Caravaca-Pérez et al. Clin Transplant. 2025 Dec.

Abstract

Background: Chronic kidney disease (CKD) is a common but poorly characterized complication in heart transplant (HT) recipients due to limited use of renal damage markers, such as albuminuria. Our aim is to determine CKD prevalence based on the Kidney Disease Improving Global Outcomes (KDIGO) criteria, assess CKD risk stratification according KDIGO guidelines, and describe the use of cardiorenal protective drugs in a contemporary HT cohort.

Methods: A cross-sectional, single-center study was conducted in stable HT recipients under follow-up in 2023. CKD was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73m2 (using CKD-EPI) and/or albumin-to-creatinine ratio (UACR) ≥ 30 mg/g. Patients were stratified into KDIGO risk categories based on eGFR and UACR thresholds.

Results: Among 207 patients (median age 65 years; 29% women; median time since transplant: 8 years), the median eGFR was 51 mL/min/1.73m2, with 58.9% having an eGFR < 60 mL/min/1.73m2 and median UACR was 45 (8-173) mg/g, with 57% showing elevated UACR. The prevalence of CKD was 79.2%, with 36 (17.4%) patients exhibiting elevated UACR despite an eGFR ≥ 60 mL/min/1.73m2. A total of 23.7%, 19.8%, 21.7%, and 34.8% were classified as low, moderate, high, and very high KDIGO risk categories, respectively. Among patients meeting the CKD criteria, 37.2% were on ACEi/ARBs and 26.2% on SGLT2i.

Conclusions: CKD is highly prevalent in HT recipients, with UACR improving diagnostic accuracy. Over half of patients fell into high-risk KDIGO categories, indicating substantial CKD severity. However, the underuse of renal-protective therapies highlights the need for better alignment with current clinical guidelines.

Keywords: albuminuria; chronic kidney disease; heart transplantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
(A) Distribution of eGFR in the studied population. (B) Correlation between eGFR and UACR. eGFR, estimated glomerular filtration rate; UACR, urine albumin‐to‐creatinine ratio.
FIGURE 2
FIGURE 2
Risk map according to KDIGO classification and risk categories of the population. UACR, urine albumin‐to‐creatinine ratio; eGFR, estimated glomerular filtration rate; KDIGO, kidney disease improving global outcomes.
See this image and copyright information in PMC

References

    1. Ojo A. O., Held P. J., Port F. K., et al., “Chronic Renal Failure After Transplantation of a Nonrenal Organ,” New England Journal of Medicine 349, no. 10 (2003): 931–940, 10.1056/NEJMoa021744. - DOI - PubMed
    1. Puttarajappa C. M., Bernardo J. F., and Kellum J. A., “Renal Complications Following Lung Transplantation and Heart Transplantation,” Critical Care Clinics 35, no. 1 (2019): 61–73, 10.1016/j.ccc.2018.08.009. - DOI - PubMed
    1. Lund L. H., Khush K. K., Cherikh W. S., et al., “The Registry of the International Society for Heart and Lung Transplantation: Thirty‐fourth Adult Heart Transplantation Report—2017; Focus Theme: Allograft Ischemic Time,” Journal of Heart and Lung Transplantation 36, no. 10 (2017): 1037–1046, 10.1016/j.healun.2017.07.019. - DOI - PubMed
    1. Levey A. S., Grams M. E., and Inker L. A., “Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease,” New England Journal of Medicine 386, no. 22 (2022): 2120–2128, 10.1056/NEJMra2201153. Ingelfinger JR, ed. - DOI - PubMed
    1. Stevens P. E., Ahmed S. B., Carrero J. J., et al., “KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease,” Kidney International 105, no. 4 (2024): S117–S314, 10.1016/j.kint.2023.10.018. - DOI - PubMed

MeSH terms